Evidence map›Paper›PMID 21570718›Full record

ArticleThe Journal of allergy and clinical immunology2011

Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia.

Miguel A de la Fuente, Mike Recher, Nicholas L Rider, Kevin A Strauss, D Holmes Morton, Margaret Adair, Francisco A Bonilla, Hans D Ochs, Erwin W Gelfand, Itai M Pessach and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 4 countries.

Miguel A de la Fuente *Division of Immunology and the Manton Center for Orphan Disease Research.
Mike Recher *Division of Immunology and the Manton Center for Orphan Disease Research.
Nicholas L RiderClinic for Special Children, Strasburg.
Kevin A StraussClinic for Special Children, Strasburg.
D Holmes MortonClinic for Special Children, Strasburg.
Margaret AdairDepartment of Pediatrics, National Jewish Health, Denver.
Francisco A BonillaDivision of Immunology and the Manton Center for Orphan Disease Research.
Hans D OchsDepartment of Pediatrics, University of Washington School of Medicine and Seattle Children's Research Institute.
Erwin W GelfandDepartment of Pediatrics, National Jewish Health, Denver.
Itai M PessachDivision of Immunology and the Manton Center for Orphan Disease Research.
Jolan E WalterDivision of Immunology and the Manton Center for Orphan Disease Research.
Alejandra KingImmunology Unit, Hospital Luis Calvo Mackenna, Santiago.
Silvia Giliani"Angelo Nocivelli" Institute for Molecular Medicine and Department of Pediatrics, University of Brescia.
Sung-Yun PaiDivision of Hematology, Children's Hospital Boston.
Luigi D NotarangeloDivision of Immunology and the Manton Center for Orphan Disease Research.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center · USClinic for Special Children · USUniversity of Colorado Denver · USBoston Children's Hospital · USFranklin & Marshall College · USHospital Luis Calvo Mackenna · CLSeattle Children's Hospital · USUniversity of Brescia · IT

Funding

Role of TACI mutations in CVIDP01AI076210 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TERHORST, CORNELIS P · 2009 to 2013
$9.0M
NIAID NIH HHS P01 AI076210
6 · The paper itself

Abstract

backgroundCartilage-hair hypoplasia (CHH) is characterized by metaphyseal dysplasia, bone marrow failure, increased risk of malignancies, and a variable degree of immunodeficiency. CHH is caused by mutations in the RNA component of the mitochondrial RNA processing (RMRP) endoribonuclease gene, which is involved in ribosomal assembly, telomere function, and cell cycle control.

objectivesWe aimed to define thymic output and characterize immune function in a cohort of patients with molecularly defined CHH with and without associated clinical immunodeficiency.

methodsWe studied the distribution of B and T lymphocytes (including recent thymic emigrants), in vitro lymphocyte proliferation, cell cycle, and apoptosis in 18 patients with CHH compared with controls.

resultsPatients with CHH have a markedly reduced number of recent thymic emigrants, and their peripheral T cells show defects in cell cycle control and display increased apoptosis, resulting in poor proliferation on activation.

conclusionThese data confirm that RMRP mutations result in significant defects of cell-mediated immunity and provide a link between the cellular phenotype and the immunodeficiency in CHH.

Indexed as

AdolescentApoptosisCell CycleCell SeparationChildChild, PreschoolFemaleFlow CytometryGenotypeHairHirschsprung DiseaseHumansImmunologic Deficiency SyndromesInfantMaleMutationRMRP non-coding RNA, humanRNA, Long NoncodingRNA, Untranslated

Identifiers

PMID21570718
PMCPMC4287238
OpenAlexW2023538990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.